King John C 4
4 · Ra Pharmaceuticals, Inc. · Filed Apr 18, 2019
Insider Transaction Report
Form 4
King John C
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-04-16−15,329→ 30,658 total→ Common Stock (15,329 underlying) - Tax Payment
Common Stock
2019-04-16$21.93/sh−4,506$98,817→ 10,823 total - Exercise/Conversion
Common Stock
2019-04-16+15,329→ 15,329 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest or have vested in three substantially equal installments on each of April 16, 2019, April 16, 2020, and April 16, 2021.
- [F3]Not applicable.